Yes, PlexusDx compounded semaglutide from licensed 503A pharmacies qualifies as an FSA-eligible medical expense when prescribed by a physician for a documented condition like obesity, diabetes, or prediabetes
Drugs like semaglutide (marketed as Ozempic and Wegovy) mimic the GLP-1 hormone, enhancing insulin secretion, suppressing appetite, and slowing gastric emptying, thereby promoting weight loss
The FDA label recommends more frequent INR monitoring when initiating or changing semaglutide doses in patients on warfarin
Joe Rogan credits the peptide for clearing up his elbow tendonitis in two weeks
These can add excess calories and undermine the progress achieved with weight loss injection Mounjaro
Semaglutide, a medication known for managing diabetes and aiding weight loss, functions as a GLP-1 receptor agonist